The following is a searchable and filterable list of our news posts, press releases, white papers, articles, scientific posters, and much more.
If you can’t find something, please let us know and we’ll reach out to you as soon as we can.
Malignant Melanoma: Landscape of Molecular Markers
Winter, M et al. Biomedicines 2026Open resourceMolecular Pathology of Advanced NSCLC: Biomarkers and Therapeutic Decisions
Winter, M et al. Cancers 2026Open resourceMolecular tumor board for gynecologic malignancies: the real-world experience from the Department for Gynecology and Gynecologic Oncology of Kliniken Essen-Mitte
Tsibulak, Irina et al. International Journal of Gynecological Cancer. 2025; 35(2):100054. doi: 10.1016/j.ijgc.2024.100054Open resourceDetermination of endometrial cancer molecular subtypes using a whole exome-sequencing based single-method approach
Mustea A et al. J Cancer Res Clin Oncol. 2024; 150(7):367. https://doi.org/10.1007/s00432-024-05901-4Open resourceA multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC
Schell, MJ et al. Nat Commun. 2016; 7:11743. doi: 10.1038/ncomms11743Open resourceBioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer
Malgerud, L. et al. Mol Oncol. 2017; 11(10):1413-1429. doi: 10.1002/1878-0261.12108Open resourceConsolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide
Hirotsu, Y. et al. Int J Mol Sci. 2020; 21(11):3895. doi: 10.3390/ijms21113895Open resourceWhole Exome Analysis to Select Targeted Therapies for Patients with Metastatic Breast Cancer – A Feasibility Study
Jaeger, BAS. Geburtshilfe Frauenheilkd. 2023; 83(9):1138-1147. doi: 10.1055/a-2150-9440Open resourceDetermination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide
Mustea, A. et al. Cancers. 2023; 15(7). doi: 10.3390/cancers15072053Open resourceEvaluation of the TruSight Tumor 170 Assay and Its Value in Clinical Diagnostics
Heydt, C. et al. J. Mol. Pathol. 2022; 3(1):53-67; https://doi.org/10.3390/jmp3010006Open resource